ADMIT-50/500 TABLETS(SITAGLIPTIN+METFORMIN HCL)
Each film coated tablet contains:
Sitagliptin (as Phosphate Monohydrate)…… 50mg
Metformin HCl…… 500mg
Admit (Sitagliptin / Metformin) is indicated as
- Initial therapy in patients with type II diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control.
- As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin.
- In triple combination with Peroxisome Proliferator-Activated Receptor gamma (PPAR) agonist (Thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of Metformin and PPAR agonist.
- In patients with type II diabetes mellitus as an adjunct to diet and exercise to improve glycemic control in combination with insulin.
Available in pack of 2 x 7 tablets